CEO of Pfizer Creates New Treatment Pill Projected to be Available by the End of 2021

CEO of Pfizer Creates New Treatment Pill Projected to be Available by the End of 2021

The Pfizer pill is described as a “game-changer.”

An oral pill is expected to treat variants of COVID-19. The CEO of Pfizer announced that an antiviral treatment for the disease could be available to the public by the end of 2021.

A news article in the UK says Pfizer is currently conducting trials in the U.S. and Belgium, where adult volunteers are taking pills to help find a “cure” for COVID-19. Pfizer CEO Albert Bourla said “it is accurate” to say the company is “working on” such therapies. The company is actually testing two antivirals, one that is injected and one that is taken orally.

Bourla explained Pfizer is focusing on the oral option because it provides multiple advantages, including people not coming to the hospital. He described the oral antiviral pill as a “game changer.” He says the end of the year is a reasonable time frame for availability to the public, all depending on the success of the trials and FDA approval.

Although it’s still new, Pfizer announced the beginning of Phase 1 clinical trials of the drug - PF-07321332 - in late March. An article says it’s designed to work by stopping SARS-CoV-2 from replicating in the cell.

"Tackling the Covid-19 pandemic requires both prevention via vaccine and targeted treatment for those who contract the virus," said Mikael Dolsten, Pfizer's chief scientific officer, "Given the way that SARS-CoV-2 is mutating and the continued global impact of COVID-19, it appears likely that it will be critical to have access to therapeutic options both now and beyond the pandemic."

More than 296 million* COVID-19 vaccines have been administered in the U.S. so far.

About the Author

Shereen Hashem is the Associate Content Editor for Occupational Health & Safety magazine.

Download Center

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • Online Safety Training Buyer's Guide

    Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • COVID Return-to-Work Checklist, Fall 2021

    Use this checklist as an aid to help your organization return to work during the COVID-19 pandemic in a safe and healthy manner.

  • SDS Buyer's Guide

    Learn to make informed decisions while searching for SDS Management Software.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Industry Safe

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - October 2021

    October 2021

    Featuring:

    • TRAINING
      On Route To Safe Material Handling
    • SAFETY CULTURE
      Normalization of Deviations in Performance
    • IH:INDOOR AIR QUALITY
      Arresting Fugitive Dusts
    • PPE:FOOT PROTECTION
      Safety Shoes Make the Outfit for Well-Protected Workers
    View This Issue